Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 1, 1998, Pages 75-85

  Kilgore, Kenneth S ^a   Park, James L ^a   Tanhehco, Elaine J ^a   Booth, Erin A ^a   Marks, Rory M ^a   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chemokines; Complement system; Cytokines; Myocardium; Neutrophils

Indexed keywords

COMPLEMENT COMPONENT C6; COMPLEMENT MEMBRANE ATTACK COMPLEX; INTERLEUKIN 8;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEMENT DEFICIENCY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOHISTOCHEMISTRY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

ANIMALIA; MYCOBACTERIUM AVIUM COMPLEX (MAC); ORYCTOLAGUS CUNICULUS;

EID: 0031890261     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0573     Document Type: Article

References (36)

1. ABE Y, KAWAKAMI M, YAMAMOTO T, FUJII M, KABAYASHI H, YAGINUMA T, KASHII A, SAITO M, MATSUSHIMA K, 1993. Transient rise in serum IL-8 concentration during acute myocardial infarction. Br Heart J 70: 132-134.
2. BROADDUS VC, BOYLAN AM, HOEFFEL JM, KIM KJ, SADICK M, CHUNTHARAPAI A, HEBERT CA, 1994. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol 152: 2960-2965.
3. CHEN CC, MANNING AM, 1996. TGF-beta 1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 8: 58-65.
4. DREYER WJ, MICHAEL LH, WEST MS, SMITH CW, ROTHLEIN R, ROSSEN RD, ANDERSON DC, ENTMAN ML, 1991. Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 84: 400-411.
5. EMBER JA, SANDERSON SD, HUGLI TE, MORGAN EL, 1994. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol 144: 393-403.
6. FINN A, NAIK S, KLEIN N, LEVINSKY RJ, STROBEL S, ELLIOTT M, 1993. Changes in neutrophil CD11b/CD18 and L-selectin expression and release of IL-8 and elastase in paediatric cardiopulmonary bypass. Agents Actions 38: C44-C46.
7. FOLKESSON HG, MATTHAY MA, HEBERT CA, BROADDUS VC, 1995. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 96: 107-116.
8. HATTORI R, HAMILTON KK, FUGATE RD, MCEVER RP, SIMS PJ, 1989a. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 264: 7768-7771.
9. HATTORI R, HAMILTON KK, MCEVER RP, SIMS PJ, 1989b. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 264: 9053-9060.
10. HERSKOWITZ A, CHOI S, ANSARI AA, WESSELINGH S, 1995. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 146: 419-428.
11. ITO W, SCHAFER HJ, BHAKDI S, KLASK R, HANSEN S, SCHAARSCHMIDT S, SCHOFER J, HUGO F, HAMDOCH T, MATHEY D, 1996. Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrythmias: a comparison between C6-competent and C6-deficient rabbits. Cardiovasc Res 32: 294-305.
12. IVEY CL, WILLIAMS FM, COLLINS PD, JOSE PJ, WILLIAMS TJ, 1995. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit: evidence for a role for C5a and interleukin-8. J Clin Invest 95: 2720-2728.
13. KALFIN RE, ENGELMAN RM, ROUSOU JA, FLACK JE, DEATON DW, KREUTZER DL, DAS DK, 1993. Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation 88: 401-406.
14. KARAKURUM MR, SHREENIWAS R, CHEN J, PINSKY D, YAN SD, ANDERSON M, SUNOUCHI K, MAJOR J, HAMILTON T, KUWABARA ??, 1994. Hypoxic induct on of interleukin-8 gene expression in human endothelial cells. J Clin Invest 93: 1564-1570.
15. KILGORE KS, SHEN J, MILLER BF, WARD PA, WARREN JS, 1995. Enhancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of ICAM-1 and E-selectin. J Immunol 155: 1434-1441.
16. X. J Cardiovasc Pharmacol Therapeut 1: 49-56.
17. KILGORE KS, MILLER BF, FLORY CM, EVANS VM, WARREN JS, 1996b. The membrane attack complex of complement induces monocyte chemoattractant protein-1 and interleukin-8 secretion from human umbilical vein endothelial cells. Am J Path 149: 953-961.
18. KUKIELKA GL, SMITH CW, LAROSA GL, MANNING AM, MENDOZA LH, DALY TJ, HUGHS BJ, YOUKER KA, HAWKINS HK, MICHAEL LH, ROT A, ENTMAN ML, 1995. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 95: 89-103.
19. LANGLOIS PF, GAWRYL MS, 1985. Detection of the terminal complement complex in patient plasma following acute myocardial infarction. Atherosclerosis 70: 95-105.
20. LOVETT DG, HAENSCH GM, GOPPELT M, RESCH K, GEMSA D, 1987. Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol 138: 2473-2481.
21. LUCCHESI BR, 1993. Complement activation, neutrophils and oxygen radicals in reperfusion injury. Stroke 24: 141-147.
22. MACLEAN D, FISHBEIN MC, BRAUNWALD E, MARKO PR, 1978. Long term preservation of ischaemic myocardium after experimental coronary artery occlusion. J Clin Invest 61: 541-551.
23. MATHEY D, SCHOFER J, SCHAFER HJ, HAMDOCH T, JOACHIM HC, RITGEN A, HUGO F, BHAKDI S, 1994. Early accumulation of the terminal complement-complex in the ischemic myocardium after reperfusion. Eur Heart J 15: 418-423.
24. MORGAN BP, 1989. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 264: 1-14.
25. MULLIGAN MS, HEVEL JM, MARLETTA MA, WARD P, 1991. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 88: 6338-6343.
26. PASCUAL M, CATANA E, SPERTINI F, MACON K, VOLANAKIS JE, SCHIFFERLI JA, 1990. A monoclonal antibody which blocks the function of factor D of human complement. J Immunol Meth 127: 263-269.
27. ROTH M, NAUCK M, YOUSEFI S, TAMM M, BLASER K, PERRUCHOUD AP, SIMON HU, 1996. Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J Exp Med 184: 191-201.
28. RUS HG, NICULESCU F, VLAICU R, 1987. Presence of C5b-9 complement complex and S-protein in infarcted areas with necrosis and sclerosis. Immunol Lett 16: 15-20.
29. SCHAFER H, MATHEY D, HUGO F, BHAKDI S, 1986. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol 137: 1945-1949.
30. SCHONERMARK M, DEPPISCH R, RIEDASCH G, ROTHER K, HANSCH GM, 1991. Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int Arch Allergy Appl Immunol 96: 331-341.
31. SEINO Y, IKEDA U, SEKIGUCHI H, MORITA M, KONISHI K, KASAHARA T, SHIMADA K, 1995. Expression of leukocyte chemotactic cytokines in myocardial tissue. Cytokine 7: 301-304.
32. STRIETER RM, KUNKEL SI, SHOWELL HJ, MARKS RM, 1988. Monokine-induced gene expression of a human endothelial cell-derived neutrophil chemotactic factor. Biochem Biophys Res Comm 156: 1340-1345.
33. WAN S, DESMET JM, BARVAIS L, GOLDSTEIN M, VINCENT JL, LECLERC JL, 1996. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112: 806-811.
34. WEISMAN HF, BARTOW T, LEPPO MK, MARSH HC, CARSON GR, CONCINO MF, BOYLE MP, ROUX KH, WEISFELDT ML, FEARON DT, 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146-151.
35. WHALEY K, 1985. Methods in Complement for Clinical Immunologists. New York: Churchill Livingstone, 77-139.
36. YOKOI K, MUKAIDA N, HARADA A, WATANABE Y, MATSUSHIMA K, 1997. Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. Lab Invest 76: 375-384.